CK Life Sciences Files Patent Applications for Circular mRNA TROP2 Cancer Vaccine

Clinical research results for Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-TMT) published in Nature Medicine, a top international medical journal

CHENGDU, China, April 12, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") today announced that results from a Phase 3 registrational clinical study evaluating the novel TROP2 antibody drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) for the treatment of…

CK Life Sciences Files Patent Applications for Circular mRNA TROP2 Cancer Vaccine

Breast Cancer Animal Studies Show Unprecedented Anti-Cancer Efficacy of 100% Tumor Growth Inhibition

SKIMS to set up integrated Cell & Gene Therapy Centre: Director SKIMS

Srinagar, Apr 11: Son of the soil and world-renowned researcher Dr Khalid Shah, Vice Chair of Research, Department of Neurosurgery and Director, Center for Stem Cell and Translational Immunotherapy, Brigham and Women’s Hospital and Professor, Harvard Medical School, USA, delivered an inspiring lecture on ‘Role of Cellular and Gene therapy in Brain Tumor Therapeutics’ at a CME and Research Orientation Programme organised by SKIMS- NAMS & SKIMS Re…